As Prices ‘Skyrocket,’ 20 States Sue Drug Companies for Collusion, Conspiracy
(COMMON DREAMS) Deirdre Fulton, December 15, 2016 — Twenty state attorneys general filed a lawsuit on Thursday against several pharmaceutical companies, accusing them of entering into “numerous illegal conspiracies” to fix generic drug prices at consumers’ expense.
The federal lawsuit (pdf) names generic drug-makers Heritage Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc., and Teva Pharmaceuticals USA, Inc., and concerns two drugs: doxycycline hyclate delayed release, an antibiotic used to treat a range of conditions including respiratory tract infections, and glyburide, an oral diabetes medication.
It was filed in the U.S. District Court for the District of Connecticut and labels Heritage as the “principal architect and ringleader” that helped organize a “wide-ranging series of conspiracies” to fix prices.